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The aim of the work was to understand the toxicity, physically significant descriptors and 
pharmaceutically relevant properties of some imidazoles obtained from the open sources that may 
found to be active against tuberculosis. At present five azoles were modeled for the prediction and 




Current treatment of tuberculosis (TB) is based on drugs that are more than 40 years old. 
Drugs that are active against resistant forms of TB are less potent, more toxic, and need to be taken 
for a long time (18 months). The recent emergence of virtually untreatable extensively drug-resistant 
TB (XDR-TB) poses a new threat to TB control worldwide. Furthermore, effective treatment of TB 
in persons co infected with HIV is complicated due to drug–drug interactions.  
 
Shorter and simpler regimens that are safe, well tolerated, effective against drug-susceptible 
and drug-resistant TB, appropriate for joint HIV–TB treatment, and amenable to routine 
programmatic conditions are needed urgently.  
 
The recent treatment of tuberculosis  
 
WHO recommends the universal use of the 6-month rifampin throughout Short Course 
Chemotherapy (SCC) regimen for the treatment of drug-susceptible TB. For MDR-TB and XDR-
TB are, however, complicated due to long duration, high toxicity, poor tolerance, and high cost, 
resulting in poor outcomes. But found that some of the nitroimidazoles belonging to a novel class of 





































antimicrobacterial agents are active against drug susceptible and drug resistant organism for the 
treatment of MDRTB [2].  
At present a study of ADME (Absorption Distribution Metabolism Elimination) of certain 
azoles was analyzed for predicting the ADME properties prior to expensive experimental 
procedures, such as HTS, can eliminate unnecessary testing on compounds that are doomed to fail, 
it can also focus lead optimization efforts to enhance the desired ADME properties. Finally, 
incorporating ADME predictions as a part of the development process will result in lead 
compounds that are more likely to exhibit satisfactory ADME performances during clinical trials 
 
Nearly 40% of drug candidates fail in clinical trials due to poor ADME properties. These 
late-stage failures contribute significantly to the skyrocketing cost of new drug development. The 
ability to detect problematic candidates early will dramatically reduce the amount of wasted time and 
resources, and streamline the overall development process. 
 
Materials and methods 
 
We used the following molecules for the toxicity prediction. 
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The molecules obtained from the open source was modeled, minimized and were uploaded for the 
descriptor and toxicity prediction and the results were tabulated in the respective tables 1, 2 and 3.  
 
Results and Discussions 
 





S.No. Descriptors Molecule 1 Molecule2  Molecule 3 Molecule 4 Molecule 5 Range 


































































































7.0 / 200.0 
10 Rotatable bonds 4 
 
4 5 4 5 0.0 /  15.0 




























































0.75 / 0.95 


























































































































































3 3 3 3 1.0 / 8.0 
11 CNS 
 
-1 -1 -1 0 -1 (-- to ++)      














































































      
16 Rule Of Five 
 
0 0 0 0 0 Maximum 
is 4 
17 Rule Of 
Three 
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Molecule 1 Timiperone, Benperidol, Quinestradol                               
Talniflumate, Metergoline                                  
86.33, 85.32, 85.22, 84.63, 84.45 
2 Molecule 2 and 
molecule 4 
Talniflumate ,Metergoline, Tioclomarol   
Quinestradol, Estramustine                                  
 
87.58, 86.37, 84.76, 84.71, 84.26 
3 Molecule 3 and 
molecule 5 
Talniflumate, Losartan, Tioclomarol  
Perospirone, Timiperone                                    
 
88.20, 86.42, 85.77, 85.24, 84.30 
 
 
From the above results the azoles have been analyzed in such a way that the molecule 2 to5 
were violating two of the parameter in the principal descriptors and predictions for properties as 
mentioned in the tables.  Also, molecule 1 was violating the parameter solute Electron Affinity in 
principal descriptors. The molecules similar to the known compounds were also tabulated. These 
molecules are showing more drug like properties with less toxicity, for which they can be screened 
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